DI 34225.003 Digestive Listings from 1/6/86 to 5/23/02

105.00 DIGESTIVE SYSTEM

  1. Disorders of the digestive system which result in disability usually do so because of interference with nutrition and growth, multiple recurrent inflammatory lesions, or other complications of the disease. Such lesions or complications usually respond to treatment. To constitute a listed impairment, these must be shown to have persisted or be expected to persist despite prescribed therapy for a continuous period of at least 12 months.

  2. Documentation of gastrointestinal impairments should include pertinent operative findings, radiographic studies, endoscopy, and biopsy reports. Where a liver biopsy has been performed in chronic liver disease, documentation should include the report of the biopsy.

  3. Growth retardation and malnutrition. When the primary disorder of the digestive tract has been documented, evaluate resultant malnutrition under the criteria described in 105.08. Evaluate resultant growth impairment under the criteria described in 100.03. Intestinal disorders, including surgical diversions and potentially correctable congenital lesions, do not represent a severe impairment if the individual is able to maintain adequate nutrition, growth, and development.

  4. Multiple congenital anomalies. See related criteria, and consider as a combination of impairments.

     

105.01 Category of Impairments, Digestive

 

105.03 Esophageal Obstruction, caused by atresia, stricture, or stenosis, with malnutrition as described under the criteria in 105.08.

 

105.05 Chronic liver disease. With one of the following:

  1. Inoperable biliary atresia demonstrated by X-ray or surgery; or

  2. Intractable ascites not attributable to other causes, with serum albumin of 3.0 gm./100 ml. or less; or

  3. Esophageal varices (demonstrated by angiography, barium swallow, or endoscopy or by prior performance of a specific shunt or plication procedure); or

  4. Hepatic coma, documented by findings from hospital records; or

  5. Hepatic encephalopathy. Evaluate under the criteria in 112.02; or

  6. Chronic active inflammation or necrosis documented by SGOT persistently more than 100 units or serum bilirubin of 2.5 mg. percent or greater.

     

105.07 Chronic inflammatory bowel disease (such as ulcerative colitis, regional enteritis), as documented in 105.00. With one of the following:

  1. Intestinal manifestations or complications, such as obstruction, abscess, or fistula formation which has lasted or is expected to last 12 months; or

  2. Malnutrition as described under the criteria in 105.08; or

  3. Growth impairment as described under the criteria in 100.03.

     

105.08 Malnutrition, due to demonstrable gastrointestinal disease causing either a fall of 15 percentiles of weight which persists or the persistence of weight which is less than the third percentile (on standard growth charts). And one of the following:

  1. Stool fat excretion per 24 hours:

    1. More than 15 percent in infants less than 6 months.

    2. More than 10 percent in infants 6-18 months.

    3. More than 6 percent in children more than 18 months; or

  2. Persistent hematocrit of 30 percent or less despite prescribed therapy; or

  3. Serum carotene of 40 mg./100 ml. or less; or

  4. Serum albumin of 3.0 gm./100 ml. or less.


To Link to this section - Use this URL:
http://policy.ssa.gov/poms.nsf/lnx/0434225003
DI 34225.003 - Digestive Listings from 1/6/86 to 5/23/02 - 08/22/2005
Batch run: 01/27/2009
Rev:08/22/2005